HATS trial

Phase 3

Completed

• Conditions: Cancer -; 1. Undiagnosed pulmonary nodules not accessible by VATS.; 2. Pulmonary metastases suitable for wedge resection.

• Registration Number: ACTRN12605000081617
• Lead Sponsor: Gavin M Wright

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Consenting adult requiring either diagnosis of lung nodule or clearance of pulmonary metastases from sarcoma, colorectal or renal carcinoma, melanoma or germ cell tumour. Must be amenable to wedge resection. Must have PET scan to exclude extra-thoracic disease and confirm primary site control.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life scores (SF-12v2)[14 and 42 days post surgery]

Secondary Outcome Measures

Name	Time	Method
Pain scores[In 24 hours after epidural removal.];Ipsilateral lung recurrence of pulmonary metastases. [2 years];Respiratory function.[6 months];Diaphragm function.[6 months];Wound complications.[30 days]